广东省医药价格试点改革的进展与挑战  

Progress and Challenge of Drug Price Pilot Reform in Guangdong Province

作　　者：陈欢欢[1] 王高玲[1] 贾秀才 CHEN Huan-huan WANG Gao-ling JIA Xiu- cai(School of Economics and Health Management, Nanjing University of Chinese Medicine, Nanjing 210023, China)

机构地区：[1]南京中医药大学卫生经济管理学院,南京市210023

出　　处：《现代医院管理》2017年第2期35-38,共4页Modern Hospital Management

基　　金：2015年度教育部人文社会科学研究规划基金项目(15YJAZH070)

摘　　要：广东省医药价格试点改革自启动以来,目前已取得阶段性进展,积累了许多有益的经验。当然,改革进程中一些深层次的问题逐步凸显,深化改革仍面临诸多挑战。笔者通过对广东省医药价格试点改革历程、取得的初步成效以及面临的主要挑战进行梳理和分析,从理顺医疗服务比价关系、改革药品价格形成机制和强化医药价格行为监督等角度,提出有效推进医药价格改革的政策建议。Since the beginning of drug price pilot reform in Guangdong Province,periodic progress has been made and much profitable experience has been accumulated. Some underlying problems in reform highlight and there is great challenge in deepening medical reform. By combing and analyzing the process of drug price pilot reform in Guangdong Province, the preliminary results and the main challenges, price relations with medical service, the mechanism for drug price and the strengthened supervision of drug price .the authors provide effective policy suggestions for the improvement in drug price reform.

关 键 词：医药价格改革 进展 挑战 广东省 

分 类 号：R197[医药卫生—卫生事业管理]